Jane Dotson
Weight loss medication can be expensive, with a month's supply of some drugs costing over $1000. Many patients are therefore reliant on insurance coverage to help them afford these medications. However, insurance coverage for weight loss medication is not guaranteed. Medicare, for instance, is barred by law from covering weight loss medication due to safety concerns. Commercial insurers may also refuse to cover weight loss medication, instead considering weight loss a cosmetic need. Patients whose insurance covers weight loss medication may also find that their coverage is later withdrawn.
| Characteristics | Values |
|---|---|
| Cost of weight-loss medication | A month's supply can cost $1,300 |
| Insurance coverage | Payers tend not to cover weight-loss medication |
| Medicare coverage | Barred by law from covering weight-loss medication |
| Commercial insurers | Do not cover weight-loss medication |
| Reasons for lack of coverage | Weight loss considered a cosmetic/lifestyle need rather than a medical one |
| GLP-1 agonists | Covered by insurance in some cases |
| Weight-loss injectables | May not be covered by insurance unless an obesity-related medical problem is present |
| FDA-approved weight-loss medication | Wegovy, Saxenda, Zepbound |
| Side effects of GLP-1 agonists | Nausea, vomiting, diarrhea, dizziness, mild tachycardia, headaches |
| Celebrity endorsements | Oprah Winfrey, Tracy Morgan, Amy Schumer |
Explore related products
What You'll Learn
Medicare and Medicaid do not cover weight loss medication
Weight loss drugs can be expensive, with a month's supply of some medications costing over $1,000. Despite this, Medicare and Medicaid do not cover weight loss medication. Medicare is prohibited by law from covering drugs prescribed solely for weight loss. This prohibition stems from safety concerns regarding the drug fen-phen, which was found to cause heart valve damage. The federal government therefore disallowed Medicare from covering drugs viewed as having risks that outweighed the benefits, namely cosmetic benefits.
Medicare Part D, launched in 2003, helps manage prescription drug costs as part of the Medicare Modernization Act. However, weight loss medications are excluded from Medicare Part D coverage unless they are prescribed for FDA-approved uses, such as treating Type 2 diabetes or some cardiovascular diseases.
Medicaid also does not cover weight loss medication. In 2025, the Trump administration rejected a Biden plan that would have required Medicaid to cover obesity drugs.
Commercial insurers may also not cover weight loss medication, as many consider weight loss a cosmetic need rather than a medical one. Some employers choose to exclude GLP-1 drugs from employer-sponsored health plans. However, if a patient's doctor prescribes medication that their insurer denies coverage for, they have the right to appeal their health plan's denial.
Medical Insurance in California: Is It Mandatory?
You may want to see also
Explore related products
Weight loss injectables are rarely covered by insurance
According to the KFF and the Institute for Clinical and Economic Review (ICER), weight management injectables can cost $1,300 or more for a month's supply. Even with insurance, these medications can still cost patients hundreds of dollars per month. As a result, many patients may struggle to afford these treatments and rely on their insurance coverage. However, insurance companies are often reluctant to cover these drugs. Medicare, for example, is legally prohibited from covering weight loss medications due to past safety concerns. Other insurers may also deny coverage for weight loss injectables, considering them a cosmetic or lifestyle choice rather than a medical necessity.
Some insurance plans may require prior authorization before approving coverage for weight loss injectables. Additionally, some employers choose to exclude these drugs from their employer-sponsored health plans. Ultimately, it is up to each insurer and its chief medical officer to decide whether to cover these medications. Patients whose insurance does not cover weight loss injectables may have the right to appeal their health plan's denial and seek alternative treatments or similar drugs that their insurer may cover.
While weight loss injectables may be effective, their high cost and limited insurance coverage present significant barriers for patients seeking these treatments. As a result, patients may need to explore alternative options or seek assistance from nonprofit organizations that help individuals pay for necessary medications.
Family Medical Insurance: Who's Covered Under Your Plan?
You may want to see also
Explore related products
Some employers exclude GLP-1 drugs from health plans
Weight loss medications can be expensive, with a month's supply of some drugs costing over $1,300. Payers, including commercial insurers, Medicare, and Medicaid, typically do not cover these medications. By law, Medicare is prohibited from covering weight loss drugs due to past safety concerns and because they are considered to have more cosmetic benefits than medical ones.
Some weight loss medications, such as Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide), have been approved by the FDA for chronic weight management. However, insurance coverage for these drugs varies. While some insurance plans may cover these medications, others may require prior authorization or exclude them altogether.
GLP-1 receptor agonists, including injectable medications containing semaglutide or tirzepatide, have been approved for weight loss and have gained popularity. However, insurance coverage for these drugs is not consistent. Some employers choose to exclude GLP-1 drugs from their employer-sponsored health plans due to budgetary concerns and the potential impact on insurance premiums and health system spending.
The decision to exclude GLP-1 drugs from health plans is made by each insurer and its chief medical officer. Employers consider the cost of these drugs, their clinical benefits, and the demands from their employees when setting coverage requirements. Additionally, insurance companies may only cover GLP-1 drugs for specific indications, such as treating type 2 diabetes, and may not cover them for weight management or obesity unless there is an associated medical problem.
While some employers exclude GLP-1 drugs from their health plans, others may offer coverage with additional eligibility conditions, such as imposing BMI requirements for the use of GLP-1 drugs under obesity indications. The variability in coverage for these medications highlights the ongoing debate over providing access to weight loss treatments and managing the associated costs.
Sonobello and Medical Insurance: What's Covered?
You may want to see also
Explore related products
Wegovy: a new weight loss drug not covered by insurance
Weight loss is often considered a cosmetic need rather than a medical one, and many insurers and employers who sponsor health coverage do not cover weight-loss medications. Medicare, for instance, is barred from covering weight loss medication by law due to past safety concerns.
Wegovy (semaglutide) is a new weight loss drug approved by the FDA in June 2021. It has been proven to be effective, but patients struggle to get insurance coverage for it. A month's supply of the drug costs $1300, and insurance companies are in a difficult position to cover such a high cost for a large market. Some insurers refer to the drug as a "lifestyle" or "vanity" drug, despite obesity being a risk factor for several diseases.
The FDA has approved Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease who are either overweight or obese. When a new medicine for obesity is first released, insurers may restrict access only to patients with a very high BMI or who have tried other medications. Patients whose insurance does not cover Wegovy may be able to get coverage for Ozempic, which is identical to Wegovy but in a smaller dose.
Some insurance plans require prior authorization before approving weight loss injectables. Patients whose insurers deny coverage for medically necessary treatments have the right to appeal.
Understanding Private Insurers' Role in Medicaid Coverage
You may want to see also
Explore related products
Side effects of weight loss medication
While weight-loss medications can be beneficial for some people, they are not without their risks and side effects. It is important to carefully consider these potential issues and consult a healthcare professional before starting any weight-loss medication.
Some weight-loss medications have been linked to serious health problems in the past, resulting in their removal from the U.S. market. Even with the newer drugs approved by the FDA, side effects are still possible and patients are advised to continue taking the medication as they often improve with time.
The side effects of weight-loss medication vary depending on the specific drug and how it interacts with an individual's body. Most side effects are mild and may include issues such as joint pain and sleep apnea. However, rarely, more serious side effects can occur. For example, in a study on semaglutide, participants initially lost weight but then regained some weight after a year. While blood sugar and cholesterol levels improved, the positive effects on blood pressure were reversed.
If an individual does not lose at least 5% of their starting weight after 12 weeks on the full dose of a weight-loss medication, it is recommended that they stop taking it. Additionally, if serious side effects occur at any time, it is crucial to consult a healthcare professional, who may advise discontinuing the medication or adjusting the treatment plan.
It is worth noting that the cost of weight-loss medications can be high, and insurance coverage for these treatments is not always guaranteed. As such, it is important to consider the potential financial burden when deciding whether to take weight-loss medication.
U.S.A.A. Life Insurance: Medical Exam Requirements Explained
You may want to see also
Frequently asked questions
Payers tend not to cover weight loss medications. This includes commercial insurers and Medicare and Medicaid.
Many insurers consider weight loss a cosmetic need rather than a medical one. Medicare, for instance, is barred from covering weight loss medication due to past safety concerns.
Some weight loss medications include Wegovy, Ozempic, Saxenda, and Zepbound.
Weight loss medications can be expensive, with a month's supply costing $1,300 or more.
If your insurance company denies coverage, you have the right to appeal their decision. You can also look into nonprofit organizations that can help cover medication costs.
